Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

DiaSorin Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (83)
Cancellation by sponsor (29)
COVID-19 test kit (3)

Date

2026 (18)
2025 (5)
2024 (6)
2023 (4)
2022 (7)
2021 (1)
2020 (5)
2019 (3)
2018 (3)
2017 (3)
2016 (5)
2015 (8)
2014 (12)
2013 (9)
2012 (17)
2011 (5)
2010 (4)

Search

Sponsor content

115 result(s) found, displaying 1 to 10

DiaSorin Australia Pty Ltd - Specimen receptacle IVDs (530619)

27 August 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DiaSorin Australia Pty Ltd - Specimen receptacle IVDs.
DiaSorin Australia Pty Ltd - LIAISON® CMV IgG II Plus - Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, kit, chemiluminescent immunoassay (530388)

21 August 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DiaSorin Australia Pty Ltd - LIAISON® CMV IgG II Plus - Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, kit, chemiluminescent immunoassay.
DiaSorin Australia Pty Ltd - Multiple-viruses IVDs (526548)

12 May 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DiaSorin Australia Pty Ltd - Multiple-viruses IVDs.
DiaSorin Australia Pty Ltd - Influenza virus IVDs Cancelled under Section 41GL(d) of the Act

12 June 2026

Cancellation by sponsor

Requested by DiaSorin Australia Pty Ltd
DiaSorin Australia Pty Ltd - Hepatitis B virus IVDs Cancelled under Section 41GL(d) of the Act

12 June 2026

Cancellation by sponsor

Requested by DiaSorin Australia Pty Ltd
DiaSorin Australia Pty Ltd - Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs Cancelled under Section 41GL(d) of the Act

2 June 2026

Cancellation by sponsor

Requested by DiaSorin Australia Pty Ltd
DiaSorin Australia Pty Ltd - Cytomegalovirus (Human herpesvirus 5) IVDs Cancelled under Section 41GL(d) of the Act

2 June 2026

Cancellation by sponsor

Requested by DiaSorin Australia Pty Ltd
DiaSorin Australia Pty Ltd - Rubella virus IVDs Cancelled under Section 41GL(d) of the Act

2 June 2026

Cancellation by sponsor

Requested by DiaSorin Australia Pty Ltd
DiaSorin Australia Pty Ltd - Toxoplasma IVDs Cancelled under Section 41GL(d) of the Act

2 June 2026

Cancellation by sponsor

Requested by DiaSorin Australia Pty Ltd
DiaSorin Australia Pty Ltd - Varicella zoster virus (Human herpesvirus 3) IVDs Cancelled under Section 41GL(d) of the Act

2 June 2026

Cancellation by sponsor

Requested by DiaSorin Australia Pty Ltd

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.